These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25686350)

  • 41. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
    Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
    Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
    Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of local extent of the tumor on prognosis in osteosarcoma.
    Spanier SS; Shuster JJ; Vander Griend RA
    J Bone Joint Surg Am; 1990 Jun; 72(5):643-53. PubMed ID: 2355025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management and outcome after local recurrence of osteosarcoma.
    Grimer RJ; Sommerville S; Warnock D; Carter S; Tillman R; Abudu A; Spooner D
    Eur J Cancer; 2005 Mar; 41(4):578-83. PubMed ID: 15737563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese musculoskeletal oncology group.
    Matsuo T; Sugita T; Sato K; Hotta T; Tsuchiya H; Shimose S; Kubo T; Ochi M
    Oncology; 2005; 68(4-6):375-81. PubMed ID: 16020966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteosarcoma.
    Meyers PA; Gorlick R
    Pediatr Clin North Am; 1997 Aug; 44(4):973-89. PubMed ID: 9286295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cranofacial osteosarcoma: Single institutional experience in Korea.
    Lim S; Lee S; Rha SY; Rho JK
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e149-53. PubMed ID: 23718845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Periosteal osteosarcoma: long-term outcome and risk of late recurrence.
    Rose PS; Dickey ID; Wenger DE; Unni KK; Sim FH
    Clin Orthop Relat Res; 2006 Dec; 453():314-7. PubMed ID: 16906092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteosarcoma of the flat bone.
    Lee JA; Kim MS; Koh JS; Kim MS; Kim DH; Lim JS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2010 Jan; 40(1):47-53. PubMed ID: 19892781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
    Chang KJ; Kong CB; Cho WH; Jeon DG; Lee SY; Lim I; Lim SM
    Skeletal Radiol; 2015 Apr; 44(4):529-37. PubMed ID: 25431093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
    Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.
    Pratt CB; Meyer WH; Rao BN; Pappo AS; Fleming ID; Luo X; Cain A; Kaste SC; Shearer PD; Jenkins JJ
    Cancer; 1997 Sep; 80(6):1171-7. PubMed ID: 9305720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic challenges in low-grade central osteosarcoma.
    Khal AA; Aiba H; Righi A; Gambarotti M; Atherley O'Meally AO; Manfrini M; Donati DM; Errani C
    Bone Joint J; 2024 Jan; 106-B(1):99-106. PubMed ID: 38160683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The surgical management of primary osteosarcoma.
    Sweetnam R
    Clin Orthop Relat Res; 1975 Sep; (111):57-64. PubMed ID: 1057465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CORR Insights(®): Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?
    Beebe KS
    Clin Orthop Relat Res; 2016 Mar; 474(3):684-6. PubMed ID: 26092679
    [No Abstract]   [Full Text] [Related]  

  • 60. Osteosarcoma of the Mandible: A Site-Specific Study on Survival and Prognostic Factors.
    Chen YM; Shen QC; Gokavarapu S; Ong HS; Cao W; Ji T
    J Craniofac Surg; 2016 Nov; 27(8):1929-1933. PubMed ID: 28005728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.